Floatz logo

Fampridine

Vestibular Diseases

Massachusetts Eye and Ear InfirmarySmall moleculePhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Vestibular Diseases cohort.

Asset / SponsorPhaseRating
ATENOLOL
Massachusetts Eye and Ear Infirmary
Phase 2CCC

Same molecule, other indications

Fampridine is also rated in:

primary progressive multiple sclerosisDormant
BBB
Indicative ·
73 / 100
View asset →
secondary progressive multiple sclerosisDormant
BBB
Indicative ·
73 / 100
View asset →
multiple sclerosisDormant
BBB
Indicative ·
72 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →